Tags

Type your tag names separated by a space and hit enter

Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
Respir Med. 2008 Jan; 102(1):92-101.RM

Abstract

Chronic respiratory diseases affect a large number of subjects in Italy and are characterized by high socio-health costs. The aim of the Social Impact of Respiratory Integrated Outcomes (SIRIO) study was to measure the health resources consumption and costs generated in 1 year by a population of patients with chronic obstructive pulmonary disease (COPD) in a real-life setting. This bottom-up, observational, prospective, multicentric study was based on the collection of demographic, clinical, diagnostic, therapeutic and outcome data from COPD patients who reported spontaneously to pneumological centers participating in the study, the corresponding economic outcomes being assessed at baseline and after a 1-year survey. A total of 748 COPD patients were enrolled, of whom 561 [408 m, mean age 70.3 years (SD 9.2)] were defined as eligible by the Steering Committee. At the baseline visit, the severity of COPD (graded according to GOLD 2001 guidelines) was 24.2% mild COPD, 53.7% moderate and 16.8% severe. In the 12 months prior to enrollment, 63.8% visited a general practitioner (GP); 76.8% also consulted a national health service (NHS) specialist; 22.3% utilized Emergency Care and 33% were admitted to hospital, with a total of 5703 work days lost. At the end of the 1-year survey, the severity of COPD changed as follows: 27.5% mild COPD, 47.4% moderate and 19.4% severe. Requirement of health services dropped significantly: 57.4% visited the GP; 58.3% consulted an NHS specialist; 12.5% used Emergency Care and 18.4% were hospitalized. Compared to baseline, the mean total cost per patient decreased by 21.7% (p<0.002). In conclusion, a significant reduction in the use of health resources and thus of COPD-related costs (both direct and indirect costs) was observed during the study, likely due to a more appropriate care and management of COPD patients.

Authors+Show Affiliations

Divisione di Pneumologia, Ospedale Orlandi, Bussolengo, Verona, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

17881206

Citation

Dal Negro, R W., et al. "Costs of Chronic Obstructive Pulmonary Disease (COPD) in Italy: the SIRIO Study (social Impact of Respiratory Integrated Outcomes)." Respiratory Medicine, vol. 102, no. 1, 2008, pp. 92-101.
Dal Negro RW, Tognella S, Tosatto R, et al. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med. 2008;102(1):92-101.
Dal Negro, R. W., Tognella, S., Tosatto, R., Dionisi, M., Turco, P., & Donner, C. F. (2008). Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respiratory Medicine, 102(1), 92-101.
Dal Negro RW, et al. Costs of Chronic Obstructive Pulmonary Disease (COPD) in Italy: the SIRIO Study (social Impact of Respiratory Integrated Outcomes). Respir Med. 2008;102(1):92-101. PubMed PMID: 17881206.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). AU - Dal Negro,R W, AU - Tognella,S, AU - Tosatto,R, AU - Dionisi,M, AU - Turco,P, AU - Donner,C F, Y1 - 2007/09/19/ PY - 2007/03/08/received PY - 2007/08/01/revised PY - 2007/08/05/accepted PY - 2007/9/21/pubmed PY - 2008/8/15/medline PY - 2007/9/21/entrez SP - 92 EP - 101 JF - Respiratory medicine JO - Respir Med VL - 102 IS - 1 N2 - Chronic respiratory diseases affect a large number of subjects in Italy and are characterized by high socio-health costs. The aim of the Social Impact of Respiratory Integrated Outcomes (SIRIO) study was to measure the health resources consumption and costs generated in 1 year by a population of patients with chronic obstructive pulmonary disease (COPD) in a real-life setting. This bottom-up, observational, prospective, multicentric study was based on the collection of demographic, clinical, diagnostic, therapeutic and outcome data from COPD patients who reported spontaneously to pneumological centers participating in the study, the corresponding economic outcomes being assessed at baseline and after a 1-year survey. A total of 748 COPD patients were enrolled, of whom 561 [408 m, mean age 70.3 years (SD 9.2)] were defined as eligible by the Steering Committee. At the baseline visit, the severity of COPD (graded according to GOLD 2001 guidelines) was 24.2% mild COPD, 53.7% moderate and 16.8% severe. In the 12 months prior to enrollment, 63.8% visited a general practitioner (GP); 76.8% also consulted a national health service (NHS) specialist; 22.3% utilized Emergency Care and 33% were admitted to hospital, with a total of 5703 work days lost. At the end of the 1-year survey, the severity of COPD changed as follows: 27.5% mild COPD, 47.4% moderate and 19.4% severe. Requirement of health services dropped significantly: 57.4% visited the GP; 58.3% consulted an NHS specialist; 12.5% used Emergency Care and 18.4% were hospitalized. Compared to baseline, the mean total cost per patient decreased by 21.7% (p<0.002). In conclusion, a significant reduction in the use of health resources and thus of COPD-related costs (both direct and indirect costs) was observed during the study, likely due to a more appropriate care and management of COPD patients. SN - 0954-6111 UR - https://www.unboundmedicine.com/medline/citation/17881206/Costs_of_chronic_obstructive_pulmonary_disease__COPD__in_Italy:_the_SIRIO_study__social_impact_of_respiratory_integrated_outcomes__ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0954-6111(07)00356-3 DB - PRIME DP - Unbound Medicine ER -